Company Profiles

driven by the PitchBook Platform

Miragen Therapeutics

Description

Developer of cardiovascular and muscle disease therapeutics. The company focuses on developing RNA-targeting therapies to improve human health, with a specific focus on microRNAs and disease areas of high unmet medical need.

2007

Founded

PRIVATE

Status

11-50

Employees

Series C

Latest Deal Type

$41.1M

Latest Deal Amount

$72.1M

Total Amount Raised

Description

Developer of cardiovascular and muscle disease therapeutics. The company focuses on developing RNA-targeting therapies to improve human health, with a specific focus on microRNAs and disease areas of high unmet medical need.

Website:

www.miragentherapeutics.com

Formerly Known As

358th Shelf

Ownership Status

Privately held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Biotechnology

Other Industries

Drug Discovery

Primary Office

6200 Lookout Road Suite 100 Boulder, CO 80301United States +1 (303) 531-5952
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore Miragen Therapeutics's full profile, request a free trial.

Miragen Therapeutics Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

Miragen Therapeutics Cap Table

Stock# of Shares
Authorized
Par ValueDividend Rate (%)Original
Issue Price
LiquidationLiquidation
Pref. Multiple
Conversion
Price
% Owned

Miragen Therapeutics Investors (13)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
Amgen VenturesCorporate Venture CapitalMinority000 0000000 0000
Arca BiopharmaCorporationMinority000 0000000 0000
Atlas VentureVenture CapitalMinority000 0000000 0000
Boulder VenturesVenture CapitalMinority000 0000000 0000
Brace Pharma CapitalOtherMinority000 0000000 0000
Amgen Ventures Corporate Venture Capital
Arca Biopharma Corporation
Atlas Venture Venture Capital
Boulder Ventures Venture Capital
Brace Pharma Capital Other

Miragen Therapeutics Executive Team (7)

NameTitleBoard
Seat
Contact
Info
William Marshall Ph.DChief Executive Officer, Co-Founder, Board Member & President
Jason LeveroneChief Financial Officer
Christopher MorlChief Operating Officer
Adam LevyChief Business Officer
David Rodman MDExecutive Vice President, Research & Development
William Marshall Ph.D Chief Executive Officer, Co-Founder, Board Member & President
Jason Leverone Chief Financial Officer
Christopher Morl Chief Operating Officer
Adam Levy Chief Business Officer
David Rodman MD Executive Vice President, Research & Development

Miragen Therapeutics Board Members (6)

NameRepresentingRoleSinceContact
Info
Bruce Booth Ph.DSelfCo-Founder & Chairman000 0000
John CreecyRemeditex VenturesBoard Member000 0000
Joshua Resnick MDMRL VenturesBoard Member000 0000
Kyle LefkoffBoulder VenturesBoard Member000 0000
Marvin Caruthers Ph.DMiragen TherapeuticsCo-Founder & Board Member000 0000
Bruce Booth Ph.D Co-Founder & Chairman Self
John Creecy Board Member Remeditex Ventures
Joshua Resnick MD Board Member MRL Ventures
Kyle Lefkoff Board Member Boulder Ventures
Marvin Caruthers Ph.D Co-Founder & Board Member Miragen Therapeutics
Request full access to PitchBook